Lupin Lines Up Rival To Teva’s Austedo – But Not Until 2033

Israeli Firm Continues To Fight Aurobindo After Seeing Off Apotex IPR Petition

 
• By Dave Wallace
  
2033 grey numbers lettering
Lupin has a 2033 launch date for its deutetrabenazine generic • Source: Carlo Toffolo / Alamy Stock Photo

More from Legal & IP

More from Generics Bulletin